Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penny Soucy

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
BMC Cancer|October 3, 2006
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer familiesFrancine Durocher, Yvan Labrie, Penny Soucy, et al.
Frontiers in Genetics|March 20, 2025
Genetic discrimination in insurance and employment based on personalized risk stratification for breast cancer screeningManuela Reveiz, Sarah Bouhouita-Guermech, Kristina M Blackmore, et al.
Plos One|June 9, 2016
ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family RegistryAnne-Laure Renault, Fabienne Lesueur, Yan Coulombe, et al.
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
Cancers|January 21, 2022
CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer SurvivalJordi Minguillón, María José Ramírez, Llorenç Rovirosa, et al.
Cancers|May 13, 2026
Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation ProjectXin Yang, Juliet A Usher-Smith, Kristina M Blackmore, et al.
NPJ Breast Cancer|September 30, 2025
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriersMei-Chee Tai, Joe Dennis, Sue K Park, et al.
Communications Medicine|April 21, 2026
Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in CanadaNareh Safieh-Garabedian, Antonis C Antoniou, Jennifer Brooks, et al.
NPJ Breast Cancer|May 13, 2021
Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjectsNa Li, Magnus Zethoven, Simone McInerny, et al.
NPJ Breast Cancer|September 23, 2020
Association of germline variation with the survival of women with <i>BRCA1/2</i> pathogenic variants and breast cancerTaru A Muranen, Sofia Khan, Rainer Fagerholm, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
BMC Cancer|October 3, 2006
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer familiesFrancine Durocher, Yvan Labrie, Penny Soucy, et al.
Frontiers in Genetics|March 20, 2025
Genetic discrimination in insurance and employment based on personalized risk stratification for breast cancer screeningManuela Reveiz, Sarah Bouhouita-Guermech, Kristina M Blackmore, et al.
Plos One|June 9, 2016
ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family RegistryAnne-Laure Renault, Fabienne Lesueur, Yan Coulombe, et al.
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
Cancers|January 21, 2022
CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer SurvivalJordi Minguillón, María José Ramírez, Llorenç Rovirosa, et al.
Cancers|May 13, 2026
Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation ProjectXin Yang, Juliet A Usher-Smith, Kristina M Blackmore, et al.
NPJ Breast Cancer|September 30, 2025
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriersMei-Chee Tai, Joe Dennis, Sue K Park, et al.
Communications Medicine|April 21, 2026
Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in CanadaNareh Safieh-Garabedian, Antonis C Antoniou, Jennifer Brooks, et al.
NPJ Breast Cancer|May 13, 2021
Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjectsNa Li, Magnus Zethoven, Simone McInerny, et al.
NPJ Breast Cancer|September 23, 2020
Association of germline variation with the survival of women with <i>BRCA1/2</i> pathogenic variants and breast cancerTaru A Muranen, Sofia Khan, Rainer Fagerholm, et al.
Pageof 8